JP2023509422A5 - - Google Patents

Info

Publication number
JP2023509422A5
JP2023509422A5 JP2022540328A JP2022540328A JP2023509422A5 JP 2023509422 A5 JP2023509422 A5 JP 2023509422A5 JP 2022540328 A JP2022540328 A JP 2022540328A JP 2022540328 A JP2022540328 A JP 2022540328A JP 2023509422 A5 JP2023509422 A5 JP 2023509422A5
Authority
JP
Japan
Prior art keywords
independently selected
alkyl
group
substituted
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022540328A
Other languages
English (en)
Japanese (ja)
Other versions
JP7756643B2 (ja
JP2023509422A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/067483 external-priority patent/WO2021138434A1/en
Publication of JP2023509422A publication Critical patent/JP2023509422A/ja
Publication of JP2023509422A5 publication Critical patent/JP2023509422A5/ja
Application granted granted Critical
Publication of JP7756643B2 publication Critical patent/JP7756643B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022540328A 2019-12-31 2020-12-30 Sting活性に関連する状態を治療するための化合物および組成物 Active JP7756643B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962955839P 2019-12-31 2019-12-31
US62/955,839 2019-12-31
US202063090538P 2020-10-12 2020-10-12
US63/090,538 2020-10-12
PCT/US2020/067483 WO2021138434A1 (en) 2019-12-31 2020-12-30 Compounds and compositions for treating conditions associated with sting activity

Publications (3)

Publication Number Publication Date
JP2023509422A JP2023509422A (ja) 2023-03-08
JP2023509422A5 true JP2023509422A5 (cg-RX-API-DMAC7.html) 2024-01-11
JP7756643B2 JP7756643B2 (ja) 2025-10-20

Family

ID=74206237

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022540328A Active JP7756643B2 (ja) 2019-12-31 2020-12-30 Sting活性に関連する状態を治療するための化合物および組成物

Country Status (8)

Country Link
US (1) US20230127839A1 (cg-RX-API-DMAC7.html)
EP (1) EP4085051A1 (cg-RX-API-DMAC7.html)
JP (1) JP7756643B2 (cg-RX-API-DMAC7.html)
CN (2) CN115348957B (cg-RX-API-DMAC7.html)
PY (1) PY2089159A (cg-RX-API-DMAC7.html)
TW (1) TW202136239A (cg-RX-API-DMAC7.html)
UY (1) UY39006A (cg-RX-API-DMAC7.html)
WO (1) WO2021138434A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI873098B (zh) 2018-07-03 2025-02-21 瑞士商諾華製藥公司 用於治療與sting活性相關之病症的化合物及組合物
JP2024500877A (ja) 2020-12-22 2024-01-10 アイエフエム デュー インコーポレイテッド がんを処置する方法
JP2024500874A (ja) 2020-12-22 2024-01-10 アイエフエム デュー インコーポレイテッド がんを処置する方法
JP2024504002A (ja) 2020-12-22 2024-01-30 アイエフエム デュー インコーポレイテッド がんを処置する方法
US20240122903A1 (en) 2020-12-22 2024-04-18 Ifm Due Inc. Methods of treating cancer
WO2022150560A1 (en) * 2021-01-08 2022-07-14 Ifm Due, Inc. Compounds and compositions for treating conditions associated with sting activity
JP2024502474A (ja) 2021-01-08 2024-01-19 アイエフエム デュー インコーポレイテッド Sting活性に関連する状態を治療するための、尿素を有するヘテロ二環式化合物または類似体およびその組成物
CN116981668A (zh) * 2021-04-09 2023-10-31 百济神州(北京)生物科技有限公司 制备bcl-2抑制剂的中间体的方法
AU2022326463A1 (en) 2021-08-10 2024-02-22 Novartis Pharma Ag Compounds and compositions for treating conditions associated with sting activity
WO2024064358A1 (en) 2022-09-23 2024-03-28 Ifm Due, Inc. Compounds and compositions for treating conditions associated with sting activity
CN117756698A (zh) * 2022-12-16 2024-03-26 中国药科大学 脲类化合物及其作为sting抑制剂的医药用途
CN116023321B (zh) * 2022-12-30 2024-11-29 中国药科大学 Sting抑制剂前药及其医药用途
CN120794957A (zh) * 2024-05-14 2025-10-17 中国药科大学 苯并含氮杂环类sting抑制剂及其医药用途
CN120794982A (zh) * 2024-05-14 2025-10-17 中国药科大学 吡唑类sting抑制剂及其医药用途
WO2026023667A1 (ja) * 2024-07-25 2026-01-29 カルナバイオサイエンス株式会社 フェニルピペラジン誘導体

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5783558A (en) * 1980-11-13 1982-05-25 Asahi Chem Ind Co Ltd Novel organic compound and its preparation
JPS5783557A (en) * 1980-11-14 1982-05-25 Asahi Chem Ind Co Ltd Novel azomethine compound and its preparation
US20120046290A1 (en) * 1997-12-22 2012-02-23 Jacques Dumas Inhibition of p38 kinase activity using substituted heterocyclic ureas
KR20040047869A (ko) 2001-09-26 2004-06-05 파마시아 이탈리아 에스.피.에이. 키나제 억제제로서 활성인 아미노인다졸 유도체, 이의제조방법 및 이를 함유하는 약제학적 조성물
US7927613B2 (en) 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
DE102005038947A1 (de) 2005-05-18 2006-11-30 Grünenthal GmbH Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln
US8188113B2 (en) 2006-09-14 2012-05-29 Deciphera Pharmaceuticals, Inc. Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
JP2013545740A (ja) 2010-11-10 2013-12-26 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング バニロイド受容体リガンドとしての置換された複素芳香族カルボキサミド誘導体および尿素誘導体
WO2012075380A1 (en) 2010-12-03 2012-06-07 The Trustees Of The University Of Pennsylvania Tip60 inhibitors
CN102516153B (zh) 2011-12-14 2014-03-12 南京工业大学 5-氟吲哚-2-酮-3-脲类化合物及其制备方法和应用
AU2014278231B2 (en) 2013-06-11 2017-05-25 KALA BIO, Inc. Urea derivatives and uses thereof
AU2014340269B2 (en) 2013-10-21 2018-06-21 Drexel University Use of STING agonists to treat chronic hepatitis B virus infection
CN107417478B (zh) 2017-06-05 2020-05-05 南京师范大学 一种催化氧化羰基化合成不对称二取代脲的方法
EP3556362A1 (en) 2018-04-16 2019-10-23 Ecole Polytechnique Federale De Lausanne (Epfl) Sting inhibitors
WO2020191227A1 (en) * 2019-03-20 2020-09-24 Cornell University Methods for controlling prostaglandin-mediated biological processes
JP2024500877A (ja) * 2020-12-22 2024-01-10 アイエフエム デュー インコーポレイテッド がんを処置する方法
US20240122903A1 (en) * 2020-12-22 2024-04-18 Ifm Due Inc. Methods of treating cancer
JP2024504002A (ja) * 2020-12-22 2024-01-30 アイエフエム デュー インコーポレイテッド がんを処置する方法
JP2024500874A (ja) * 2020-12-22 2024-01-10 アイエフエム デュー インコーポレイテッド がんを処置する方法

Similar Documents

Publication Publication Date Title
JP2022535743A5 (cg-RX-API-DMAC7.html)
JP2022538228A5 (cg-RX-API-DMAC7.html)
JP2021534124A5 (cg-RX-API-DMAC7.html)
AR082681A1 (es) Inhibidores del virus de la hepatitis c
JP2022548696A5 (cg-RX-API-DMAC7.html)
JP2019013227A5 (cg-RX-API-DMAC7.html)
RU2002131941A (ru) 3-азот-6,7-дикислородсодержащие стероиды и их применение
JP2021534108A5 (cg-RX-API-DMAC7.html)
RU2006131132A (ru) 1,3,5,-тризамещенные производные 4,5-дигидро-1н-пиразола, обладающие св1-антагонистической активностью
SI2961736T1 (en) Histone demethylase inhibitors
RU2013123790A (ru) Ингибиторы cdk
JP2009530424A5 (cg-RX-API-DMAC7.html)
JP2023513373A5 (cg-RX-API-DMAC7.html)
JP2024529527A5 (cg-RX-API-DMAC7.html)
RU2010113358A (ru) Гуанидинсодержащие соединения, применимые в качестве антагонистов мускариновых рецепторов
JP2024502473A5 (cg-RX-API-DMAC7.html)
RU2007130144A (ru) Гетероциклические соединения в качестве антагонистов cccr2b
JP2024525368A5 (cg-RX-API-DMAC7.html)
JP2025505200A5 (cg-RX-API-DMAC7.html)
JP2025503945A5 (cg-RX-API-DMAC7.html)
RU2010136721A (ru) Агонисты мускариновых рецепторов, композиции, способы лечения ими и способы их изготовления
RU2007116987A (ru) Новые соединения
JP2021514399A5 (cg-RX-API-DMAC7.html)
JP2024112835A5 (cg-RX-API-DMAC7.html)
JP2017137323A (ja) 新規抗がん剤